Dyne Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -400 | -386 | ||
EBITDA | -96,658 | -105,221 | -71,962 | -68,771 |
EBIT | -97,108 | -105,659 | -72,361 | -69,157 |
Net Income | -89,542 | -97,125 | -65,102 | -65,649 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -85,410 | -74,882 | -55,725 | -78,728 |
Cash | 435,449 | 532,163 | 608,196 | 272,035 |
Basic Shares | 101,982 | 100,882 | 92,507 | 81,043 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,461 | -3,345 | -1,088 | |
EBITDA | -343,886 | -233,476 | -169,279 | -148,203 |
EBIT | -235,937 | -170,962 | -149,291 | |
Net Income | -317,418 | -235,937 | -165,237 | -149,283 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -294,745 | -188,887 | -156,712 | -123,181 |
Cash | 435,449 | 121,626 | 172,147 | 200,825 |
Basic Shares | 94,143 | 59,683 | 51,976 | 50,895 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.88 |
2024-09-30 | -$0.96 |
2024-06-30 | -$0.70 |
2024-03-31 | -$0.81 |
